Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shi‐Xun Lu
Observed names:
S X Lu,
Shi-Xun Lu,
Shi-xun Lu,
Shixun Lu
Institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
OpenAlex ID:
A5110696312
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer
2023
·
Tin-Lok Wong
, Jia-Jian Loh
, et al.
·
Nature Communications
·
110
PDF
Retracted: HB x‐mediated decrease of AIM 2 contributes to hepatocellular carcinoma metastasis
2017
·
Shi‐Lu Chen
, Li‐Li Liu
, et al.
·
Molecular Oncology
·
90
PDF
PD-1 antibody camrelizumab for Epstein-Barr virus-positive metastatic gastric cancer: a single-arm, open-label, phase 2 trial.
2021
·
Yu-Ting Sun
, Wen-Long Guan
, et al.
·
PubMed
·
39
Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis
2021
·
Cen-Shan Lin
, Yuyi Liang
, et al.
·
Cancer Letters
·
34
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma
2022
·
Jun-Cheng Wang
, Dong-Ping Chen
, et al.
·
Cancer Research
·
29
PDF
Observational cohort study of clinical outcome in Epstein–Barr virus associated gastric cancer patients
2020
·
Miao-Zhen Qiu
, Cai-Yun He
, et al.
·
Therapeutic Advances in Medical Oncology
·
29
PDF
Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer
2022
·
Ming-Yu Lai
, Shi-Yang Kang
, et al.
·
BMC Cancer
·
28
PDF
Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
2013
·
Rongzhen Luo
, Meifang Zhang
, et al.
·
PLoS ONE
·
27
PDF
Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer
2023
·
Fulong Wang
, Shixun Lu
, et al.
·
OncoImmunology
·
23
PDF
A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma
2019
·
Lei Shi
, Shu-Jun Zhang
, et al.
·
Modern Pathology
·
23
PDF
Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature
2022
·
Jian-Ying Xu
, Wen-Long Guan
, et al.
·
Clinical Medicine Insights Oncology
·
22
Spatial transcriptome unveils a discontinuous inflammatory pattern in proficient mismatch repair colorectal adenocarcinoma
2022
·
Rongxin Zhang
, Yu Feng
, et al.
·
Fundamental Research
·
21
PDF
α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study
2021
·
Shi-Xun Lu
, Yu-Hua Huang
, et al.
·
British Journal of Cancer
·
19
PDF
Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma
2024
·
Yu-Ting Sun
, Shi-Xun Lu
, et al.
·
Cancer Immunology Immunotherapy
·
17
Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal‐invasive gastric cancer patients
2019
·
Mingzhe Ma
, Shixun Lu
, et al.
·
Cancer Medicine
·
10
PDF
The relationship between brain metastasis and HER2 expression status in gastric cancer
2023
·
Ming-Yu Lai
, Wen-Long Guan
, et al.
·
Clinical & Translational Oncology
·
9
Identification of Two Subgroups of FOLFOX Resistance Patterns and Prediction of FOLFOX Response in Colorectal Cancer Patients
2020
·
Sun Tian
, Fulong Wang
, et al.
·
Cancer Investigation
·
7
PDF
The correlation between mismatch repair status and clinicopathological characteristics in Chinese colorectal cancer patients.
2017
·
Zhi-tao Xiao
, Rong-xin Zhang
, et al.
·
Journal of Clinical Oncology
·
5
Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment
2023
·
Fulong Wang
, Shixun Lu
, et al.
·
Frontiers in Immunology
·
4
[Correlation between mismatch repair proteins status and clinicopathological characteristics in sporadic colorectal cancer patients].
2017
·
Z T Xiao
, R X Zhang
, et al.
·
PubMed
·
4
Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer
2025
·
Di Cao
, Guang-Zhao Lv
, et al.
·
Annals of Surgery
·
3
Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer
2020
·
Xue Chao
, Zixian Wang
, et al.
·
International Journal of Clinical Oncology
·
3
Abstract 3547: FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2
2014
·
Li-Li Liu
, Shi-Xun Lu
, et al.
·
Cancer Research
·
3
Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
2025
·
Rongxin Zhang
, Fulong Wang
, et al.
·
MedComm
·
2
PDF
The prevalence of PD-L1 expression in patients with advanced oesophageal cancer: the EXCEED observational study
2025
·
Liyan Xue
, Jiaqi Wang
, et al.
·
Journal of Clinical Pathology
PDF
Show more works
View as search
Works count:
43
Citation count:
561
H-index:
14
I10-index:
15
Year
Topic
Type